Mark Boguniewicz spends much of his time researching Atopic dermatitis, Immunology, Allergy, Atopy and Psoriasis. His Atopic dermatitis research is classified as research in Dermatology. His Dermatology research is multidisciplinary, incorporating elements of Susceptibility gene, Adverse effect and 2,4-Dinitrochlorobenzene.
His Immunology study often links to related topics such as Skin infection. His Allergy study frequently links to related topics such as Asthma. His biological study spans a wide range of topics, including Guideline, Clinical immunology and Eczema Area and Severity Index.
Mark Boguniewicz mostly deals with Atopic dermatitis, Dermatology, Immunology, Allergy and Atopy. His research on Atopic dermatitis focuses in particular on Eczema Area and Severity Index. As a part of the same scientific study, Mark Boguniewicz usually deals with the Dermatology, concentrating on Quality of life and frequently concerns with Cross-sectional study.
His study in Immunology concentrates on Immunopathology, Immune system, Psoriasis, Immunoglobulin E and Innate immune system. His Allergy research is multidisciplinary, incorporating perspectives in Incidence and Cytokine. The study incorporates disciplines such as Skin biopsy and Pathogenesis in addition to Cytokine.
His primary areas of study are Atopic dermatitis, Dermatology, Dupilumab, Dermatology Life Quality Index and Severity of illness. Atopic dermatitis and In patient are two areas of study in which Mark Boguniewicz engages in interdisciplinary research. The Dermatology study combines topics in areas such as Moderate to severe, Exacerbation, Phosphodiesterase 4 Inhibitor and Adult patients.
His Dupilumab research is multidisciplinary, relying on both Lebrikizumab, Eczema Area and Severity Index, Immune dysregulation, Tralokinumab and Post-hoc analysis. His research in Severity of illness intersects with topics in Disease and Comorbidity. His work deals with themes such as Crisaborole and Immunology, which intersect with Boxed warning.
His primary areas of investigation include Atopic dermatitis, Quality of life, Severity of illness, Dermatology Life Quality Index and Internal medicine. To a larger extent, Mark Boguniewicz studies Dermatology with the aim of understanding Atopic dermatitis. His study looks at the relationship between Severity of illness and topics such as Comorbidity, which overlap with Hay fever, Disease, Pharmacotherapy and Alopecia areata.
The various areas that he examines in his Dupilumab study include Clinical trial, Regimen, Randomized controlled trial, Adverse effect and Concomitant. His work carried out in the field of Asthma brings together such families of science as Psychological intervention, Family medicine, Allergy, Public health and Transplantation. His Eczema Area and Severity Index study is concerned with Immunology in general.
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Peck Y. Ong;Takaaki Ohtake;Corinne Brandt;Ian Strickland.
The New England Journal of Medicine (2002)
New insights into atopic dermatitis
Donald Y.M. Leung;Mark Boguniewicz;Michael D. Howell;Ichiro Nomura.
Journal of Clinical Investigation (2004)
Cytokine modulation of atopic dermatitis filaggrin skin expression
Michael D. Howell;Byung Eui Kim;Peisong Gao;Audrey V. Grant.
The Journal of Allergy and Clinical Immunology (2007)
Atopic Dermatitis: A Disease of Altered Skin Barrier and Immune Dysregulation
Mark Boguniewicz;Donald Y. M. Leung.
Immunological Reviews (2011)
Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.
Qutayba Hamid;Mark Boguniewicz;Donald Y. M. Leung.
Journal of Clinical Investigation (1994)
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report
C A Akdis;M Akdis;T Bieber;C Bindslev-Jensen.
Cytokine Milieu of Atopic Dermatitis, as Compared to Psoriasis, Skin Prevents Induction of Innate Immune Response Genes
Ichiro Nomura;Elena Goleva;Michael D. Howell;Quatyba A. Hamid.
Journal of Immunology (2003)
Tight junction defects in patients with atopic dermatitis.
Anna De Benedetto;Nicholas M. Rafaels;Laura Y. McGirt;Andrei I. Ivanov.
The Journal of Allergy and Clinical Immunology (2011)
In vivo expression of IL-12 and IL-13 in atopic dermatitis
Qutayba Hamid;Tanveer Naseer;Eleanor M. Minshall;Yan L. Song.
The Journal of Allergy and Clinical Immunology (1996)
Atopic dermatitis: A practice parameter update 2012
Lynda Schneider;Stephen Tilles;Peter Lio;Mark Boguniewicz.
The Journal of Allergy and Clinical Immunology (2013)
If you think any of the details on this page are incorrect, let us know.